China National Pharmaceutical Group Co Ltd (Sinopharm) is a centrally-administered State-owned enterprise under the direct management of the State-owned Assets Supervision and Administration Commission of the State Council (SASAC). Sinopharm is a globally leading company in the healthcare sector in terms of scale, performance and comprehensive strength. With a primary focus on life & health, the company owns a complete industrial chain covering R&D, manufacturing, logistics and distribution, retail chains, healthcare, engineering technology, exhibitions and events, international business and financial services.